2024年10月30日，基因诊断公司Genedx Holdings(股票代码:WGS)股价出现明显反弹,盘中一度大涨5.24%,收盘时报88.22美元/股,引发了市场的广泛关注。
在最新公布的财报数据中,Genedx Holdings实现营业收入7051万美元,净利润亏损2917万美元,每股亏损1.10美元。该公司业务主要集中在基因组测序和基因诊断领域,其基因组数据库被认为是全球最大的罕见疾病数据集之一。
不过,虽然Genedx Holdings股价出现大涨,但新闻报道并未透露明确的推动因素。分析人士认为,这可能与投资者对该公司长期增长前景的看好有关。半数分析师对该股给予买入评级,看好其在精准医疗领域的竞争优势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.